Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02158949 · ClinicalTrials.gov registry record · NA
Study of Mobile Phone Delivered Intervention to Reduce Alcohol Consumption
A NA study of Alcohol Abuse, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT02158949: Completed NA study of Alcohol Abuse, sponsored by University of Southern California.
NCT02158949 is a NA study of Alcohol Abuse that has completed, run by University of Southern California. The registered enrollment target is 48 participants, below the 712-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02158949, a NA study of Alcohol Abuse, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, the investigators will be developing and testing a mobile phone text message intervention to reduce alcohol use for people at risk of alcohol dependence. The investigators hypothesize that this intervention will be acceptable to participants, and that they will stay in the intervention until it's one week completion.
Primary Outcome
percentage of patients that do not opt out of messages prior to 1 week completion
Conditions Studied
Interventions
- BEHAVIORAL mROAD
Study Locations (1)
California
- LAC+USC Medicine Center Emergency Department - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2014-05-01 |
| Est. Completion | 2014-07-31 |
| Phase | NA |
What the finished NCT02158949 record still lists
NCT02158949 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 712-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Alcohol Abuse appearing as the primary indexed condition, and to 1 intervention - of which mROAD is the first listed.
NCT02158949 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02158949 about?
NCT02158949 is a clinical study titled "Study of Mobile Phone Delivered Intervention to Reduce Alcohol Consumption". In this study, the investigators will be developing and testing a mobile phone text message intervention to reduce alcohol use for people at risk of alcohol dependence. The investigators hypothesize that this intervention will be acceptable to participants, and that they will stay in the interventio...
What is the current status of trial NCT02158949?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2014-05-01. Estimated completion is 2014-07-31.
What conditions does trial NCT02158949 study?
This clinical trial studies the following conditions: Alcohol Abuse.
What interventions are being tested in trial NCT02158949?
The interventions under investigation include: mROAD (BEHAVIORAL).
Who is sponsoring clinical trial NCT02158949?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02158949 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02158949's enrollment target sits among peer trials
48 39th of 46 higher than 8 of 46 other Alcohol Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Mobile App for Latinx Hazardous Drinkers With Clinical Anxiety
RECRUITING · NA
-
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
RECRUITING · NA
-
Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
RECRUITING · NA
-
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI